The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p

Title
The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p
Authors
Keywords
Osteoarthritis, Chondrocyte hypertrophy, miR-149-5p, JAK inhibitor (tofacitinib), Therapeutics
Journal
BONE
Volume 151, Issue -, Pages 116024
Publisher
Elsevier BV
Online
2021-05-28
DOI
10.1016/j.bone.2021.116024

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started